X4 Pharmaceuticals Receives Orphan Drug Designation from the U.S. FDA for X4P-001-RD for the Treatment ...
(WorldNews Health)

CAMBRIDGE, Mass.--(BUSINESS WIRE)--X4 Pharmaceuticals has received Orphan Drug Designation from the U.S. FDA for X4P-001-RD for the treatment of WHIM syndrome. ......